2022
DOI: 10.1016/j.ejmg.2022.104597
|View full text |Cite
|
Sign up to set email alerts
|

EIF4ENIF1 variants in two patients with non-syndromic premature ovarian insufficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…We propose that eIF4ENIF1-mediated repression of eIF4E1b-bound maternal mRNAs in P-bodies is also important for vertebrate oogenesis and embryogenesis. Mutations in eIF4ENIF1 cause infertility in women (Kasippillai et al, 2013 ; Zhao et al, 2019 ; Shang et al, 2022 ), in agreement with both eIF4E1b and eIF4ENIF1 working together to regulate maternal mRNA dormancy.…”
Section: Discussionmentioning
confidence: 76%
“…We propose that eIF4ENIF1-mediated repression of eIF4E1b-bound maternal mRNAs in P-bodies is also important for vertebrate oogenesis and embryogenesis. Mutations in eIF4ENIF1 cause infertility in women (Kasippillai et al, 2013 ; Zhao et al, 2019 ; Shang et al, 2022 ), in agreement with both eIF4E1b and eIF4ENIF1 working together to regulate maternal mRNA dormancy.…”
Section: Discussionmentioning
confidence: 76%
“…Binding of eIF4ENIF1 to eIF4Es has been shown to stabilize deadenylated mRNAs in human cells (Räsch et al, 2020). Mutations in eIF4ENIF1 also cause infertility in women (Kasippillai et al, 2013;Zhao et al, 2019;Shang et al, 2022), in agreement with both eIF4E1B and eIF4ENIF1 working together to promote maternal mRNA dormancy.…”
Section: Discussionmentioning
confidence: 85%
“…In mouse oocytes, knocking‐down Eif4enif1 leads to failure of the oocyte nuclear envelop breakdown and oocyte development arrest (Pfender et al., 2015). To date, five different single‐heterozygous variants in EIF4ENIF1 segregating in an autosomal dominant manner have been found in patients with premature ovarian insufficiency (POI; França et al., 2020; Kasippillai et al., 2013; Shang et al., 2022; Zhao et al., 2019). Four of these variants are missenses predicted by the ACMG (Richards et al., 2015) to be benign/likely benign, and only one is protein‐truncating predicted to be VUS and segregating with the phenotype in a large family.…”
Section: Discussionmentioning
confidence: 99%